← FDA DRUG APPROVALS
FDA ANDA · ANDA204613
CIPROFLOXACIN HCL OPHTHALMIC
ciprofloxacin hydrochloride
Sponsor: ALTAIRE PHARMS INC
APPLICATION
ANDA204613
TYPE
ANDA
ORIGINAL APPROVAL
2018-05-03
LATEST ACTION
2018-05-03
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription
Products
CIPROFLOXACIN HYDROCHLORIDEPrescription
CIPROFLOXACIN HYDROCHLORIDE EQ 0.3% BASE · SOLUTION/DROPS · OPHTHALMIC
Approval history
2018-05-03UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.